Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...

Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

Medtronic expects the separation of its diabetes business to be immediately profitable and improve margins, as diabetes devices require unique commercial and manufacturing strategies. The company ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than 8,000 global employees and carry a nearly $3 billion portfolio of ...

Medtronic (NYSE: MDT) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great. However, it also ...

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision. The group at the time was ...

Medtronic PLC’s stock fell 7.3% as the worst performer in the S&P 500 on Tuesday after the medical-products company’s earnings fell slightly short of Wall Street’s revenue target despite a ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Medtronic is among the world’s largest makers of medical devices. - Jenn Ackerman for WSJ Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the ...

Under Medtronic’s plan, the new unnamed company will also be publicly traded, Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year ...